THE REVIVAL OF INTEREST IN NITROFURANTOIN

Parijat Das, Raghu Sriram, Kumar Anand Shrutiraaj

Abstract


Urinary Tract Infection (UTI) are among the most common bacterial infections that lead patients to seek medical care. Nitrofurantoin is an excellent option for treatment of acute uncomplicated UTI. Aim of the study is to determine the sensitivity profile of Nitrofurantoin in patients with UTI and compare it with sensitivity profile of Norfloxacin and Cotrimoxazole. Overall sensitivity to Nitrofurantoin Norfloxacin and Cotrimoxazole in this study was found to be 67% 27% and 47%. Sensitivity of Escherichia coli to Nitrofurantoin was 84%.  Nitrofurantoin is an excellent option for treating acute uncomplicated UTI on OPD basis.

Keywords


Urinary Tract Infection, Nitrofurantoin, resistance, bactericidal

Full Text:

PDF

References


Verest LF, van Esch WM, van Ree JW, Stobberingh EE. (2000), “Management of acute uncomplicated urinary tract infections in general practice in the south of The Netherlands.” British Journal of General Practice, 50(453):309–310.

Huang Elbert S, Stafford Randall S. (2002), “National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.” Archives of Internal Medicine, 162(1):41–47.

Foxman B. (2002), “Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.” The American Journal of Medicine, 113 Supplement, 1:5-13.

Zalmanovici Trestioreanu A, Green H, Paul M, Yaphe J, Leibovici L. (2010), “Antimicrobial agents for treating uncomplicated urinary tract infection in women.” Cochrane Database Systemic Review, CD007182.

Strom BL, Collins M, West SL, Kreisberg J, Weller S. (1987), “Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriurea: a case-control study.” Archives of Internal Medicine, 107:816-823.

Hooton TM, Scholes D, Hughes JP, et al. (1996), “A prospective study of risk factors for symptomatic urinary tract infection in young women.” New England Journal of Medicine, 335:468-474.

Hooton TM, Stamm WE. (1997), “Diagnosis and treatment of uncomplicated urinary tract infection.” Infectious Disease Clinic of North America, 11:551-581.

Cunha BA, Shoch PE, Hage JR. (2011), “Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections.” Mayo Clinic Proceedings, 86:1243-1248.

Guay DR. (2001), “An update on the role of nitrofurans in the management of urinary tract infections.” Drugs, 61:353-64.

McOsker CC, Fitzpatrick PM. (1994), “Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens.” Journal of Antimicrobial Chemotherapy, 33 Suppl A: 23-30.

Harding GKM, Ronald AR. (1994), “The management of urinary infec¬tions: What have we learned in the past decade?” International Journal of Antimicrobial Agents, 4:83-8.

Garau J. (2008), “Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: Fosfomycin, nitrofurantoin and tigecycline.” Clinical Microbiology and Infection, 14 Suppl 1:198-202.

Mazzei T, Cassetta MI, Fallani S, Arrigucci S, Novelli A. (2006), “Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.” International Journal of Antimicrobial Agents, 28 Suppl 1:S35-41.

European Committee on Antimicrobial Susceptibility Testing. (2010), “Nitrofurantoin: Rationale for the Clinical Breakpoints, Version 1.0” Available at: http://www.eucast.org/antimicrobial_susceptibility_testing/breakpoints/.

Munoz-Davila MJ. (2014), “Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of loweer urinary tract infections.” Antibiotics, 3:39-48.

Duff P. (2002), “Antibiotic selection in obstetrics: Making cost-effective choices.” Clinical Obstetrics and Gynecology, 45:59-72.

Ronald AR, Turck M. (1967), “Comparison of oxafuradene and nitrofurantoin in vitro and clinical assessment of oxafuradene in bacteriuria.” Antimicrobial Agents and Chemotherapy (Bethesda), 7:506-9.

Barry AL. (1990), “Nitrofurantoin susceptibility test criteria.” Journal of Antimicrobial Chemotherapy, 25:711-3.

Varma NC, Taneja OP, Saxena SN. (1972), “Recurrent urinary tract infections in females.” Journal of Indian Medical Association, 58: 155-58.

Gupta V, Yadav A, Joshis RM. (2002), “Antibiotic resistance patterns in uropathogens.” Indian Journal of Medical Microbiology, 20(2): 96-98.

Johnson JR. (1997), “Urinary tract infection. In: Sussman M, editor Escherichia coli: mechanisms of virulence”. Cambridge University Press, 495-549.

Syed Mustaq Ahmed, Ramakrishna Pai Jakribettu, Shaniya Koyakutty, Arya B, ShakirVPA. (2012), “Urinary Tract Infections – An overview on the Prevalence and the Anti-biogram of Gram Negative Uropathogens in A Tertiary Care Centre in North Kerala, India.” Journal of Clinical and Diagnostic Research, 6(7):1192-1195.

Salwa Alkhyat H, Maher Ali Al. Maqtari. (2014), “Prevalence of Microorganisms isolates from Urinary Tract Infections at Some Hospitals in Sana'a City, Yemen.” International Journal of Current Microbiology and applied Sciences, 3(6):876-885.

Johnson JR, Stamm W. (1987), “Diagnosis and treatment of acute urinary tract infections” [published correction appears in Infectious Disease Clinic of North America.1990;4(2):following xii] Infectious Disease Clinic of North America, 1(4):773-791.

Kahlmeter G. (2003), “An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.” Journal of Antimicrobial Chemotherapy, 51:69-76.

Gupta K, Hooton TM, Naber KG, et al. (2011), “International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.” Clinical Infectious Diseases, 52:e103-e120.

Spencer RC, Moseley DJ, Greensmith MJ. (1994), “Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice.” Journal of Antimicrobial Chemotherapy, 33(suppl A):121-129.

Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. (2006), “Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance.” Indian Journal of Medical Sciences, 60:53-8.

Smita Sood, Ravi Gupta. (2012), “Antibiotic Resistance Pattern of Community Acquired Uropathogens at a Tertiary Care Hospital in Jaipur, Rajasthan.” Indian Journal of Community Medicine, 37(1):39-44.

Sahni RD, Balaji V, Varghese R, John J, Tansarli GS, Falagas ME. (2013), “Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: A prospective study.” Future Microbiology, 8:675-80.

Parijat Das, Vipin Pathak, Kumar Shrutiraaj. (2019), "Bacterial Uropathogens from Patients of Symptomatic Benign Prostatic Hyperplasia at a Tertiary Care Hospital in India." International Journal of Science and Research, Volume 8 Issue 11, 822 – 825.

Kothari A, Sagar V. (2008), “Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.” The Journal of Infection in developing Countries, 2:354-358.

Akram M, Shahid M, Khan AU. (2007), “Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.” Annals of Clinical Microbiology and Antimicrobials, 6:4.


Refbacks

  • There are currently no refbacks.